Mark E. Fleury
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- Lymphatic System and Diseases
- Cell Biology top 5%
- Cellular Mechanics and Interactions
Papers in
-
- Ethics in Clinical Research 10
-
- Health Systems, Economic Evaluations, Quality of Life 6
- Economic and Financial Impacts of Cancer 4
- Co-authors
- Melody A. Swartz (4 shared papers)Joseph M. Unger (11 shared papers)Dawn L. Hershman (5 shared papers)Riha Vaidya (5 shared papers)Lori M. Minasian (3 shared papers)Alice A. Tomei (1 shared paper)Jacqueline D. Shields (1 shared paper)Gwendalyn J. Randolph (1 shared paper)
- Journals
- Journal of Clinical Oncology (7 papers)Cancer (3 papers)JAMA Oncology (3 papers)JAMA Network Open (3 papers)JNCI Journal of the National Cancer Institute (2 papers)
- Partner nations
- United StatesSwitzerlandItaly
In The Last Decade
Mark E. Fleury
26 papers receiving 2.3k citations
Mark E. Fleury's Hit Papers
Peers
Comparison fields: 5 of 133
- Oncology 721
- Cell Biology 407
- Health Informatics 30
- Modeling and Simulation 68
- Public Health, Environmental and Occupational Health 372
Countries citing papers authored by Mark E. Fleury
This map shows the geographic impact of Mark E. Fleury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Fleury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Fleury more than expected).
Fields of papers citing papers by Mark E. Fleury
This network shows the impact of papers produced by Mark E. Fleury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Fleury. The network helps show where Mark E. Fleury may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Fleury, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 495 | |
| 2 | 2007 | 478 | |
| 3 | Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation Hit paper breakdown → | 2018 | 365 |
| 4 | 2005 | 233 | |
| 5 | 2020 | 166 | |
| 6 | 2006 | 139 | |
| 7 | 2019 | 121 | |
| 8 | 2021 | 49 | |
| 9 | 2024 | 41 | |
| 10 | 2022 | 39 | |
| 11 | 2021 | 35 | |
| 12 | 2022 | 31 | |
| 13 | 2020 | 29 | |
| 14 | 2021 | 25 | |
| 15 | 2013 | 23 | |
| 16 | 2018 | 21 | |
| 17 | 2024 | 12 | |
| 18 | 2020 | 12 | |
| 19 | 2023 | 9 | |
| 20 | 2023 | 7 |
About Mark E. Fleury
Mark E. Fleury is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics, Physiology, Molecular Biology and Oncology, having authored 29 papers that have together received 2.3k indexed citations. Recurring topics across this work include Ethics in Clinical Research (10 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Biomedical Ethics and Regulation (5 papers), Economic and Financial Impacts of Cancer (4 papers), Cellular Mechanics and Interactions (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Pharmaceutical studies and practices (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Oncology (721 citations), Cell Biology (407 citations), Health Informatics (30 citations), Modeling and Simulation (68 citations) and Public Health, Environmental and Occupational Health (372 citations). Mark E. Fleury has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include Melody A. Swartz, Joseph M. Unger, Dawn L. Hershman, Riha Vaidya, Lori M. Minasian, Alice A. Tomei, Jacqueline D. Shields, Gwendalyn J. Randolph, Federica Boschetti and Andreas H. Zisch. Their work appears in journals such as Journal of Clinical Oncology, Cancer, JAMA Oncology, JAMA Network Open and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.